{"paper_id":"9cf5b0a8-5cb8-4ed2-bcab-c2b35127e329","body_text":"Abstract\nEndometriosis is a common disease characterised by ectopic growth of endometrial tissue outside the uterine cavity. Angiogenesis has been implicated in the pathogenesis of the disease; some molecules, like hypoxia-inducible factor-1α (HIF-1α) and neuronal, endothelial and inducible nitric oxide synthase isoforms (nNOS, eNOS and iNOS), are known as proangiogenetic factors. We evaluated expression of these molecules by immunohistochemistry in 32 cases of ovarian endometriomas, formalin-fixed and paraffin-embedded. Analysis was focused on the cells composing the inner layer of the cyst, constituted by the ectopic endometrial glands, stromal cells and vessels, and the outer one, constituted by a fibrous layer of fibroblasts and vessels. We found that epithelial glands and capsular vessel endothelial cells showed a correlated expression of NOS isoforms; that expression of nNOS, iNOS and HIF-1α was correlated in epithelial glands and capsular fibroblasts; that vessel endothelial cells showed a higher mean expression for all the proangiogenetic molecules in the outer layer than in the inner one; and that capsular fibroblasts showed a higher mean expression for HIF-1α, iNOS and eNOS compared to the specialised stromal cells of the inner layer. Our data seem to indicate that angiogenesis is stimulated more in the outer capsule than in the inner layer of ovarian endometriotic cysts. The knowledge of the complex mechanisms associated to angiogenesis might be useful in a therapeutic approach of ovarian endometriosis based on anti-angiogenetic drugs. The therapeutic target would be mainly the capsular vasculature, more than the vasculature of ectopic endometrial tissues.\nSimilar content being viewed by others\nReferences\nNisolle M, Donnez J (1997) Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68:585–596\nGiudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799\nJenkins S, Olive DL, Haney AF (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 67:335–338\nBulun SE (2009) Endometriosis. N Engl J Med 360:268–279\nKobayashi H (2009) Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 14:378–382\nMandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I (2009) Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 14:383–391\nBecker CM, D'Amato RJ (2007) Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res 74:121–130\nGroothuis PG, Nap AW, Winterhager E, Grümmer R (2005) Vascular development in endometriosis. Angiogenesis 8:147–156\nVan Langendonckt A, Donnez J, Defrère S, Dunselman GA, Groothuis PG (2008) Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol Hum Reprod 14:259–268\nMachado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE (2008) Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 90:148–155\nDonnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13:1686–1690\nFerrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25\nMcLaren J, Prentice A, Charnock-Jones DS, Smith SK (1996) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11:220–223\nTakehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M (2004) Vascular endothelial growth factor A and C gene expression in endometriosis. Human Pathol 35:1369–1375\nGoteri G, Lucarini G, Filosa A, Pierantoni A, Montik N, Biagini G, Fabris G, Ciavattini A (2004) Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 81:1528–1533\nGarciá-Manero M, Alcazar JL, Toledo G (2007) Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain. Fertil Steril 88:513–515\nCeyhan ST, Onguru O, Baser I, Gunhan O (2008) Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertil Steril 90:988–993\nTuncay G, Kilic S, Yuksel B, Elmas C, Lortlar N, Erdogan D, Ozogul C (2009) Heterogeneous appearance of VEGF (vascular endothelial growth factor) immunopositivity in cyst capsules of endometrioma. Acta Histochem 111:61–67\nShweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845\nRyan HE, Lo J, Johnson RS (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005–3015\nWu MH, Chen KF, Lin SC, Lgu CW, Tsai SJ (2007) Aberrant expression of leptin in human endometriotic stromal cells is induced by elevated levels of hypoxia inducible factor-1α. Am J Pathol 170:590–598\nBecker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D'amato RJ (2008) 2-Methoxyestradiol inhibits hypoxia-inducible factor-1α and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 172:534–544\nGoteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, Tranquilli AL, Ciavattini A (2009) Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1α (HIF-1α), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol 28:157–163\nMoncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012\nMoncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142\nNathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915–918\nTaguchi M, Alfer J, Chwalisz K, Beier HM, Classen-Linke I (2000) Endhotelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle. Mol Hum Reprod 6:185–190\nKnowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298:249–258\nKimura H, Esumi H (2003) Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 50:49–59\nTelfer JF, Lyall F, Norman JE, Cameron IT (1995) Identification of nitric oxide synthase in human uterus. Hum Reprod 10:19–23\nTelfer JF, Irvine GA, Kohnen G, Campbell S, Cameron IT (1997) Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Mol Hum Reprod 3:69–75\nKhorram O, Lessey BA (2002) Alterations in expression of endometrial endothelial nitric oxide synthase and αvβ3 integrin in women with endometriosis. Fertil Steril 78:860–864\nOta H, Igarashi S, Hatazawa J, Tanaka T (1998) Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 69:303–308\nDong M, Shi Y, Cheng Q, Hao M (2001) Increased nitric oxide in peritoneal fluid from women with idiopathic infertility and endometriosis. J Reprod Med 46:887–891\nWu MY, Chao KH, Yang JH, Lee TH, Yang YS, Ho HN (2003) Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis. Hum Reprod 18:2668–2671\nWang J, Zhou F, Dong M, Wu R, Qian Y (2006) Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility. Fertil Steril 85:1037–1044\nOsborn BH, Haney AF, Misukonis MA, Weinberg JB (2002) Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fertil Steril 77:46–51\nScurry J, Whitehead J, Healey M (2001) Classification of ovarian endometriotic cysts. Int J Gynecol Pathol 20:147–154\nJiang BH, Liu LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochem Biophys Acta 1784:150–158\nKimura H, Weisz A, Ogura T, Hitomi H, Kurashima Y, Hashimoto K, D’ Acquisto F, Machuuki M, Esumi H (2001) Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276:2292–2298\nWu Y, Kajdacsy-Balla A, Strawn E, Basir Z, Halverson G, Jailwala P, Wang Y, Wang X, Ghosh S, Guo S-W (2006) Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 147:232–246\nMatsuzaki S, Canis M, Vaurs-Barrière C, Boespflug-Tanguy O, Dastugue B, Mage G (2005) DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil Steril 84:1180–1190\nGoteri G, Lucarini G, Pieramici T, Filosa A, Pugnaloni A, Montik N, Biagini G, Tranquilli AL, Fabris G, Ciavattini A, Lo Muzio L (2005) Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts. Anticancer Res 25:4313–4318\nTan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L (2002) Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78:148–1453\nGilabert-Estellés J, Ramòn LA, Espaňa F, Gilabert J, Vila V, Réganon E, Castellò R, Chirivella M, Estellés A (2007) Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 22:2120–2127\nConflict of interest\nThe authors declare that they have no conflict of interest.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nGoteri, G., Lucarini, G., Zizzi, A. et al. Proangiogenetic molecules, hypoxia-inducible factor-1α and nitric oxide synthase isoforms in ovarian endometriotic cysts. Virchows Arch 456, 703–710 (2010). https://doi.org/10.1007/s00428-010-0929-1\nReceived:\nRevised:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00428-010-0929-1","source_license":"public-domain-us","license_restricted":false}